Table 1.
Article | Authors | Year | No. of patients | Findings |
---|---|---|---|---|
1 [28] | Kwee et al. | 2005 | 17 | Prostate sextants positive for malignancy showed higher SUV-max than biopsy negative sextants |
2 [30] | Schmid et al. | 2005 | 19 | Only 1 out of 9 patients with 18F-FCH uptake proved to be malignant |
3 [17] | Husarik et al. | 2008 | 43 | Pathologic uptake was noted in 42 out of 43 patients with histologic proven PCa |
4 [18] | Igerc et al. | 2008 | 20 | Five out of 13 positive focal 18F-FCH uptake were malignant on pathology |
5 [29] | Kwee et al. | 2008 | 15 | Sixty one out of 90 prostate sextants with 18F-FCH uptake were malignant on pathology |
6 [15] | Beheshti et al. | 2010 | 130 | Good correlation between sections with the highest 18F-FCH uptake and malignancy |
Abbreviations: PCa, prostate cancer; 18F-FCH. [18F]fluoromethyl-dimethyl-2-hydroxyethyl-ammonium; SUV, standardized uptake value.